S
PRAH

SignatureFD’s PRA Health Sciences, Inc. PRAH Stock Holding History

SignatureFD’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-112
Closed -$19K – 3309
2021
Q2 		$19K Buy
112
+10
+10% +$1.67K ﹤0.01% 1746
2021
Q1 		$16K Buy
102
+23
+29% +$3.12K ﹤0.01% 1673
2020
Q4 		$10K Buy
79
+30
+61% +$3.35K ﹤0.01% 1723
2020
Q3 		$5K Sell
49
-50
-51% -$5.1K ﹤0.01% 1937
2020
Q2 		$10K Buy
99
+57
+136% +$5.3K ﹤0.01% 1588
2020
Q1 		$3K Buy
42
+17
+68% +$1.66K ﹤0.01% 1882
2019
Q4 		$3K Buy
25
+10
+67% +$1.03K ﹤0.01% 1842
2019
Q3 		$1K Buy
15
+12
+400% +$1.19K ﹤0.01% 2059
2019
Q2 		$0 Sell
3
-74
-96% -$7.06K ﹤0.01% 2213
2019
Q1 		$8K Hold
77
– – ﹤0.01% 1496
2018
Q4 		$7K Buy
+77
New +$7.79K ﹤0.01% 1475

Other funds holding PRAH

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

SignatureFD's PRAH Position: Q3 2021 in Review

SignatureFD sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 112 shares — an estimated $19K sold.

SignatureFD first reported a position in PRAH in Q4 2018 and held it in 11 quarters. The position peaked at $19K in Q2 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

  • SignatureFD reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
  • SignatureFD sold 112 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $19K.
  • SignatureFD first reported a position in PRA Health Sciences, Inc. in Q4 2018 and held it in 11 quarters.
  • SignatureFD's PRA Health Sciences, Inc. position peaked at $19K in Q2 2021.
  • 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on SignatureFD's 13F filing for Q3 2021, filed 28 Oct 2021.